Screener
CorMedix CRMD EBIT
Discontinued — last reported Q1 '26
EBIT at other companies
Other financials
Where this comes from
Calculated from CorMedix’s reported figures.
Plus components not separately reported this period.
The source filing: CorMedix’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
FAQ
- What is CorMedix's EBIT?
- CorMedix (CRMD) reported EBIT of $63.66M in Q1 2026.
- How has CorMedix's EBIT changed year-over-year?
- CorMedix's EBIT increased by 216.3% year-over-year, from $20.13M to $63.66M.
- What is the long-term trend for CorMedix's EBIT?
- Over 3 years (2021 to 2025), CorMedix's EBIT has grown at a 72.1% compound annual growth rate (CAGR), from -$29.44M to $150.14M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about CorMedix's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude